Literature DB >> 9020936

High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years.

H E Broxmeyer1, S Cooper.   

Abstract

Cord blood is enriched with haematopoietic stem and progenitor cells which have high levels of proliferative, replating and expansion capacity in vitro. Cryopreserved cord blood stored for up to a few years has been used as a source of transplantable cells for related and unrelated allogeneic stem cell transplantation. Information on retrieval of immature and mature subsets of viable haematopoietic progenitor cells from long-term cryopreserved cord blood is not yet available. We therefore assessed the recovery of cord blood cells stored frozen in liquid nitrogen for up to 10 years. Calculations of efficiency of recovery were possible because the exact same culture conditions were used for pre-freeze and post-thaw cells with the serum and growth factors presently used being of similar potency to those used for the studies 10 years ago. High efficiency recovery of immature and mature progenitors was found even though a relatively unsophisticated freezing procedure had been used. Recovery of nucleated cells averaged 88% and that of granulocyte-macrophage (CFU-GM), erythroid (BFU-E) and multipotential (CFU-GEMM) progenitors averaged from 74 to 91% for different populations, with some samples in each category being recovered at 100%. Recovery of immature progenitors responsive to stimulation in vitro with a colony stimulating factor plus the potent co-stimulating cytokine, steel factor, was also demonstrated, although the per cent recovery of such cells could not be calculated directly as steel factor was not available 9-10 years ago when the cells were originally frozen. While the cell populations assayed are not considered to represent long-term narrow repopulating cells, the data presented demonstrate that cells with very high proliferative capacity can be stored long term in cryopreserved form.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020936

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation.

Authors:  Shohei Yamamoto; Hirokazu Ikeda; Daisuke Toyama; Mayumi Hayashi; Kousuke Akiyama; Manabu Suzuki; Yutaka Tanaka; Tsuneki Watanabe; Yoko Fujimoto; Ichirou Hosaki; Hirokazu Nishihira; Keiichi Isoyama
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

2.  Usefulness of umbilical cord blood cells in era of hematopoiesis research.

Authors:  Seong-Kyu Park; Jong-Ho Won
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 3.  Insights into the biology of cord blood stem/progenitor cells.

Authors:  H E Broxmeyer
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

4.  Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

Authors:  Hal E Broxmeyer; Man-Ryul Lee; Giao Hangoc; Scott Cooper; Nutan Prasain; Young-June Kim; Coleen Mallett; Zhaohui Ye; Scott Witting; Kenneth Cornetta; Linzhao Cheng; Mervin C Yoder
Journal:  Blood       Date:  2011-03-10       Impact factor: 22.113

5.  Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.

Authors:  Virginia Fisher; Hanh Khuu; Virginia David-Ocampo; Karen Byrne; Steven Pavletic; Michael Bishop; Daniel H Fowler; A John Barrett; David F Stroncek
Journal:  Transfusion       Date:  2013-10-10       Impact factor: 3.157

6.  How old is too old? In vivo engraftment of human peripheral blood stem cells cryopreserved for up to 18 years - implications for clinical transplantation and stability programs.

Authors:  John Underwood; Mahvish Rahim; Carijo West; Rebecca Britton; Elaine Skipworth; Vicki Graves; Steven Sexton; Hillary Harris; Dave Schwering; Anthony Sinn; Karen E Pollok; Kent A Robertson; W Scott Goebel; Kerry M Hege
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

Review 7.  Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.

Authors:  Hal E Broxmeyer
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

8.  High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.

Authors:  Hal E Broxmeyer; Edward F Srour; Giao Hangoc; Scott Cooper; Stacie A Anderson; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

Review 9.  Human umbilical cord blood (HUCB) cells for central nervous system repair.

Authors:  Mary B Newman; Cyndy D Davis; Nicole Kuzmin-Nichols; Paul R Sanberg
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 10.  Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation.

Authors:  Hal E Broxmeyer
Journal:  Korean J Intern Med       Date:  2013-10-29       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.